Serum Levels of the Aminoterminal Propeptide of Type III Procollagen and Hyaluronan during Resolving and Nonresolving Posttransfusion non-A, non-B Hepatitis

References

• Dienstag J L, Alter H J. Non-A, non-B hepatitis: evolving epidemiological and clinical perspective. Semin Liver Dis 1986; 6: 67–81
   PubMed Web of Science ®Google Scholar
• Mattsson L, Åberg B, Weiland O, Sellman M, Davilén J. Non-A, non-B hepatitis after open-heart surgery in Stockholm: Declining incidence after introduction of restrictions for blood donations due to the human immunodeficiency virus. Scand J Infect Dis 1988; 20: 371–376
   PubMed Web of Science ®Google Scholar
• Mattsson L, Weiland O, Glaumann H. Long-term follow-up of chronic post-transfusion non-A, non-B hepatitis: clinical and histological outcome. Liver 1988; 8: 184–188
   PubMedGoogle Scholar
• Smedsrød B. Aminoterminal propeptide of type III procollagen is cleared from the circulation by receptor-mediated endocytosis in liver endothelial cells. Coll Relat Res 1988; 8: 375–388
   PubMedGoogle Scholar
• Hahn E G. Blood analysis for liver fibrosis. J Hepatol 1984; 1: 67–73
   Web of Science ®Google Scholar
• Torres-Salinas M, Parés A, Caballeria J, Jiménez W, Herdia D, Bruguera M, Rodés J. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis. Gastroenterology 1986; 90: 1241–1246
   PubMed Web of Science ®Google Scholar
• Annoni G, Cargnel A, Colombo M, Hahn E G. Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis, distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis. J Hepatol 1986; 2: 379–388
   PubMed Web of Science ®Google Scholar
• Bentsen K D, Høslev-Petersen K, Junker P, Juhl E, Lorenzen I. the Copenhagen Hepatitis Acuta Programme. Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long-term follow-up study. Liver 1987; 7: 96–105
   PubMedGoogle Scholar
• McCullough A J, Stassen W N, Wiesner R H, Czaja A J. Serial determinations of the amino-terminal peptide of type III procollagen in severe chronic active hepatitis. J Lab Clin Med 1987; 109: 55–61
   PubMed Web of Science ®Google Scholar
• McCullough A J, Stassen W N, Wiesner R H, Czaja A J. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity. Hepatology 1987; 7: 49–54
   PubMed Web of Science ®Google Scholar
• Surrenti C, Casini A, Milani S, Ambu S, Ceccatelli P, D'Agnata A. Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?. Dig Dis Sci 1987; 32: 705–709
   PubMed Web of Science ®Google Scholar
• Frei A, Zimmermann A, Weigand K. The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology 1984; 4: 830–834
   PubMed Web of Science ®Google Scholar
• Weigand K, Zaugg P Y, Frei A, Zimmermann A. Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease. Hepatology 1984; 4: 835–838
   PubMed Web of Science ®Google Scholar
• Tiribelli C. Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: its relationship to hepatic fibrosis, activity of the disease and iron overload. Hepatology 1985; 5: 475–479
   PubMed Web of Science ®Google Scholar
• Smedsrød B, Pertoft H, Eriksson E, Frazer J RE, Laurent T C. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 1984; 223: 617–626
   PubMed Web of Science ®Google Scholar
• Nyberg A, Engström-Laurent A, Lööf L. Serum hyaluronate in primary biliary cirrhosis—a biochemical marker for progressive liver damage. Hepatology 1988; 8: 142–146
   PubMed Web of Science ®Google Scholar
• Engström-Laurent A, Lööf L, Nyberg A, Schröder T. Increased serum levels of hyaluronate in liver disease. Hepatology 1985; 5: 638–642
   PubMed Web of Science ®Google Scholar
• Frébourg T, Delpech B, Bercoff E, Senant J, Bertrand P, Deugnier Y, Boureille J. Serum hyaluronate in liver diseases: Study by enzymoimmunological assay. Hepatology 1986; 6: 392–395
   PubMed Web of Science ®Google Scholar
• Lindqvist U, Weiland O, Lööf L, Mattsson L, Samuelsson K. Sequential measurements of hyaluronan and procollagen type III peptide in acute viral hepatitis, Submitted
   Google Scholar
• Rhode H, Vargas L, Hahn E, Kalbfleisch H, Bruguera M, Timpl R. Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 1979; 9: 451–459
   PubMed Web of Science ®Google Scholar
• Engström-Laurent A, Laurent U, Lilja K, Laurent T. Concentration of serum hyaluronate in serum. Scand J Clin Lab Invest 1985; 45: 497–504
   PubMed Web of Science ®Google Scholar
• Brandt R, Hedlöf E, Åsman I, Bucht A, Tengblad A. A convenient radiometric assay for hyaluronan. Acta Otolaryngol (Stockh), Suppl 1987; 442: 31–35
   PubMedGoogle Scholar
• Tengblad A. Quantitative analysis of hyaluronate in nanogram amounts. Biochem J 1980; 185: 101–105
   PubMed Web of Science ®Google Scholar
• Tengblad A. Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding proteins from cartilage. Biochem Biophys Acta 1979; 578: 281–289
   PubMed Web of Science ®Google Scholar
• Broström C, Weiland O. Ett engångsset för leverbiopsi lätthanterligt och med få komplikationer. Läkartidningen 1981; 78: 976–977, (In Swedish.)
   Google Scholar
• International group. Acute and chronic hepatitis revisited. Lancet 1977; 2: 914–919
   PubMed Web of Science ®Google Scholar
• Bensen K D, Lanng C, Hørslev-Petersen K, Risteli J. The aminoterminal propeptide of type III procollagen and basement membrane components in serum during wound healing in man. Acta Chir Scand 1988; 154: 97–101
   PubMedGoogle Scholar